| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $273.6M | +6.5% |
| Cost of Revenue | $106.4M | +5.5% |
| Gross Profit | $167.2M | +7.2% |
| R&D Expense | $50.3M | -7.4% |
| SG&A Expense | $34.4M | +9.7% |
| Operating Income | $4.3M | +161.3% |
| Pre-tax Income | $4.4M | +171.2% |
| Income Tax | -$2.1M | -374.5% |
| Net Income | $6.5M | +193.6% |
| EPS (Basic) | $0.23 | +188.5% |
| EPS (Diluted) | $0.23 | +188.5% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.1M | +12.7% |
| Accounts Receivable | $11.8M | +47.2% |
| Inventory | $16.2M | +23.8% |
| Current Assets | $66.7M | +18.8% |
| Total Assets | $227.5M | +52.5% |
| Current Liabilities | $71.7M | +38.8% |
| Long-term Debt | $51.5M | — |
| Total Liabilities |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.7M | +4.1% |
| Capital Expenditures | $5.6M | -13.3% |
| Investing Cash Flow | -$69.7M | -980.8% |
| Financing Cash Flow | $44.3M | +323.3% |
| Free Cash Flow | $22.1M | +9.6% |
| $134.6M |
| +110.6% |
| Stockholders' Equity | $92.9M | +9.0% |